Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
53
SYRE Quote, Financials, Valuation and Earnings
Last price:
$35.13
Seasonality move
:
-3.15%
Day range:
$33.16 - $35.21
52-week range:
$10.91 - $35.31
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
701.12x
P/B ratio:
5.99x
Volume:
790.5K
Avg. volume:
575.8K
1-year change:
47.19%
Market cap:
$2.7B
Revenue:
--
EPS (TTM):
-$2.18
Earnings Data
Next earnings date for SYRE
Feb 19
2026
Most recent earnings per share
-$0.18
Beat by $0.56
(Nov 4/2025)
Consensus Estimate
-$0.74
(Nov 4/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SYRE Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q1 | -- | -- | -- | -$0.68 | -- |
| 02/19/2026 | Q4 | -- | -- | -- | -$0.80 | -- |
| 11/04/2025 | Q3 | -- | -- | -$0.18 | -$0.74 | $0.56 |
| 08/05/2025 | Q2 | -- | -- | -$0.60 | -$0.71 | $0.11 |
| 05/08/2025 | Q1 | -- | -- | -$0.60 | -$0.84 | $0.24 |
| 02/27/2025 | Q4 | $2.1M | -- | -$0.79 | -$0.94 | $0.15 |
| 11/07/2024 | Q3 | -- | -- | -$1.06 | -$0.86 | -$0.19 |
| 08/07/2024 | Q2 | $2.9M | -- | -$0.59 | -$0.91 | $0.32 |
| 05/09/2024 | Q1 | -- | -- | -$0.72 | -$1.08 | $0.36 |
| 02/29/2024 | Q4 | $220K | -- | $11.58 | -$0.83 | $12.41 |
| 11/09/2023 | Q3 | -- | -- | -$9.34 | -- | -- |
| 06/30/2023 | Q2 | -- | $688K | -$56.79 | -- | -- |
| 03/31/2023 | Q1 | -- | $198K | -$4.89 | -- | -- |
| 12/31/2022 | Q4 | -- | $168K | -$7.20 | -- | -- |
| 09/30/2022 | Q3 | -- | $174K | -$4.84 | -- | -- |
| 06/30/2022 | Q2 | -- | $625K | -$6.79 | -- | -- |
| 03/31/2022 | Q1 | -- | $1.4M | -$9.26 | -- | -- |
| 12/31/2021 | Q4 | -- | $3.6M | -$10.36 | -- | -- |
| 09/30/2021 | Q3 | -- | $1.4M | -$7.72 | -- | -- |
| 06/30/2021 | Q2 | -- | $13.7M | -$2.60 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$6.94 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$11.84 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$7.24 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$10.11 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$14.15 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$18.48 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$16.40 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$13.72 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$14.79 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$15.50 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$13.55 | -- | -- |
| 06/30/2018 | Q2 | -- | $2.4M | -$11.43 | -- | -- |
| 03/31/2018 | Q1 | -- | $1.5M | -$12.17 | -- | -- |
| 12/31/2017 | Q4 | -- | $1.5M | -$9.75 | -- | -- |
| 09/30/2017 | Q3 | -- | $1.3M | -$12.00 | -- | -- |
| 06/30/2017 | Q2 | -- | $1.5M | -$11.75 | -- | -- |
| 03/31/2017 | Q1 | -- | $982K | -$11.75 | -- | -- |
| 12/31/2016 | Q4 | -- | $1.2M | -$10.25 | -- | -- |
| 09/30/2016 | Q3 | -- | $1.1M | -$11.75 | -- | -- |
| 06/30/2016 | Q2 | -- | $1.4M | -$11.50 | -- | -- |
| 03/31/2016 | Q1 | -- | $859K | -$177.50 | -- | -- |
Spyre Therapeutics, Inc. Earnings Questions
-
How Much did Spyre Therapeutics, Inc. Generate in Revenue Last Quarter?
Spyre Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Spyre Therapeutics, Inc. Beat Earnings Last Quarter?
Spyre Therapeutics, Inc. announced earnings per share of -$0.18 which represents a beat of analyst forecast a -$0.74 per share.
-
Is Spyre Therapeutics, Inc. Profitable?
Spyre Therapeutics, Inc. reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Spyre Therapeutics, Inc. EPS Next Year?
Spyre Therapeutics, Inc.'s earnings are forecast to decrease from -$3.18 per share to -$2.12 per share next year representing a decrease of -11.92%.
-
When is Spyre Therapeutics, Inc.'s Earnings Date?
Spyre Therapeutics, Inc.'s next earnings date is February 19, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Sell
40
BILL alert for Feb 7
Bill Holdings, Inc. [BILL] is up 37.11% over the past day.
Buy
75
PRLB alert for Feb 7
Proto Labs, Inc. [PRLB] is up 28.33% over the past day.
Sell
30
MSTR alert for Feb 7
Strategy, Inc. [MSTR] is up 26.08% over the past day.
